Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 545 clinical trials
T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC

This is a single arm open-label multi-center phase II study, investigating disease control rate after 3 months of treatment with trastuzumab-emtansine/osimertinib combination therapy in patients

  • 0 views
  • 03 Feb, 2021
  • 5 locations
  • 0 views
  • 27 Jan, 2021
  • 20 locations
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer

objective of the study is to evaluate the safety, tolerability, toxicity and efficacy (specifically Progression Free Survival at 5.5 month (PFS5.5mos)) of this combination therapy.

cancer
gemcitabine
gemcitabine/nab-paclitaxel
platelet count
paclitaxel
  • 47 views
  • 23 Feb, 2021
  • 2 locations
Random Trial for Elderly Patients With NSCLC

quality of life with chemotherapy. 2. The role of combination therapy containing the platinum compound, which is the standard therapy for the young patients is still vague. 3

gemcitabine
vinorelbine
carboplatin
  • 3 views
  • 07 Nov, 2020
  • 1 location
Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer

This is a single arm open-label multi-center phase II study, investigating disease control rate after 18 weeks of treatment with afatinib/cetuximab combination therapy in patients with advanced

secondary malignant neoplasm of liver
stage iv non-small cell lung cancer
systemic therapy
afatinib
epidermal growth factor
  • 20 views
  • 28 Jan, 2021
  • 4 locations
A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled Study

conflicting results, has been demonstrated to yield marginal or of no value. However the use of the combination therapy, especially with a double blind fashion have not been reported. On that basis

non-cardiac chest pain
angiography
cardiac pain
  • 39 views
  • 07 Nov, 2020
  • 1 location
MTD Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors

, RP2D, safety and efficacy of NYH817G and NYH100P in combination therapy in patients with advanced solid tumors who have failed approved standard therapies To assess the PK properties, the

  • 1 views
  • 26 Jan, 2021
  • 1 location
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

The aim of this study is to compare two therapeutical strategies concerning the combination therapy (peginterferon alfa-2a and ribavirin) in naïve patients with chronic hepatitis C of

chronic hepatitis
fibroscan
liver disease
interferon
fibrosis
  • 14 views
  • 07 Nov, 2020
  • 1 location
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

address the potential effects of combination therapy with ICS and long-acting β2 agonists (LABA). This is an important short-coming because combination therapy of ICS and LABA have been shown to

cigarette smoke
fluticasone
bronchodilator
corticosteroids
  • 130 views
  • 07 Nov, 2020
  • 9 locations
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

This study is to investigate safety and feasibility of a combination therapy of a tumor infiltrating lymphocytes (TIL) transfer with anti-programmed cell death protein (PD)-1 therapy in patients

cyclophosphamide
liver metastasis
platelet count
nivolumab
metastasis
  • 0 views
  • 14 Aug, 2021
  • 1 location